---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-05-11T00:14:15.038890'
end_time: '2026-05-11T00:32:05.872796'
duration_seconds: 1070.83
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: HSPA12B
  gene_symbol: HSPA12B
  uniprot_accession: Q96MM6
  protein_description: 'RecName: Full=Heat shock 70 kDa protein 12B; AltName: Full=Heat
    shock protein family A member 12B;'
  gene_info: Name=HSPA12B; Synonyms=C20orf60;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the heat shock protein 70 family. .
  protein_domains: ATPase_NBD. (IPR043129)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 18
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q96MM6
- **Protein Description:** RecName: Full=Heat shock 70 kDa protein 12B; AltName: Full=Heat shock protein family A member 12B;
- **Gene Information:** Name=HSPA12B; Synonyms=C20orf60;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the heat shock protein 70 family. .
- **Key Domains:** ATPase_NBD. (IPR043129)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "HSPA12B" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'HSPA12B' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **HSPA12B** (gene ID: HSPA12B, UniProt: Q96MM6) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q96MM6
- **Protein Description:** RecName: Full=Heat shock 70 kDa protein 12B; AltName: Full=Heat shock protein family A member 12B;
- **Gene Information:** Name=HSPA12B; Synonyms=C20orf60;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the heat shock protein 70 family. .
- **Key Domains:** ATPase_NBD. (IPR043129)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "HSPA12B" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'HSPA12B' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **HSPA12B** (gene ID: HSPA12B, UniProt: Q96MM6) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Research Report: Human **HSPA12B** (UniProt **Q96MM6**; gene **HSPA12B/C20orf60**) — Functional Annotation

### 0) Mandatory identity verification (gene/protein disambiguation)
The literature retrieved consistently uses **HSPA12B** to denote a **heat shock protein family A (Hsp70) member**, reported as **predominantly/endothelial-enriched** in expression and function across cardiovascular and inflammatory models, matching the UniProt description provided (human HSP70-family member). (fan2020endothelialcellhspa12b pages 1-2, zhang2020endothelialhspa12bexerts pages 1-2, tu2020novelroleof pages 1-2)

A key structural contextual source describes **HSPA12B as an atypical/distant HSP70 member** because the **nucleotide-binding domain (NBD/ATP-binding domain) is divergent** in the HSPA12 genes, with “uncharacterised nucleotide binding properties,” distinguishing it from canonical HSP70s whose NBD binds/hydrolyzes ATP to regulate substrate binding/release. (madsen2019hspa12atargetsthe pages 1-2)

### 1) Key concepts and definitions (current understanding)

#### 1.1 What HSPA12B “is” in molecular terms
**HSPA12B** is best viewed as an **atypical HSP70-family protein**. Canonical HSP70s share a characteristic architecture: an ~44 kDa **N-terminal NBD (ATPase)** and a ~28 kDa **C-terminal substrate-binding domain (SBD)**, with ATP hydrolysis controlling chaperone-substrate interactions. In contrast, **HSPA12B (and HSPA12A)** are described as exceptions in which the **NBD is divergent**, and their **nucleotide-binding properties are not yet biochemically characterised** in that source. (madsen2019hspa12atargetsthe pages 1-2)

**Functional implication:** for HSPA12B, much of the mechanistic knowledge currently derives from **cellular and in vivo pathway phenotypes** (angiogenesis/inflammation signaling) rather than from demonstrated classical HSP70 ATPase-driven chaperoning cycles. (madsen2019hspa12atargetsthe pages 1-2)

#### 1.2 Biological theme: endothelial stress-response regulator and intercellular signal
Across multiple systems, HSPA12B is repeatedly positioned as:
- an **endothelial cell–enriched factor** that regulates **vascular repair/angiogenesis**, and
- a mediator of **endothelial–immune crosstalk**, notably via **exosomes/extracellular transfer** of HSPA12B or miRNA signals. (fan2020endothelialcellhspa12b pages 1-2, zhang2020endothelialhspa12bexerts pages 13-15, tu2020novelroleof pages 1-2)

### 2) Subcellular localization and where HSPA12B acts

#### 2.1 Intracellular localization: cytosol → nucleus (stress/hypoxia)
In endothelial cells exposed to hypoxia and in post-MI hearts, HSPA12B is reported to undergo **nuclear translocation**. This nuclear localization is functionally linked to transcriptional co-regulation with YAP/TEAD4 (Hippo pathway transcriptional effectors). (fan2020endothelialcellhspa12b pages 1-2, fan2020endothelialcellhspa12b pages 6-8)

#### 2.2 Extracellular/exosomal localization: endothelial secretion → macrophage uptake
Several studies describe HSPA12B being **exported in endothelial-derived exosomes** and subsequently **taken up by macrophages**, shaping inflammatory signaling output (e.g., NF-κB activity; cytokines) and macrophage polarization. (tu2020novelroleof pages 1-2, wang2025endothelialhspa12bregulates pages 1-2)

In a cancer microenvironment context, tumor-associated endothelial cells are reported to **secrete HSPA12B**, which is then taken up by macrophages, implicating HSPA12B as an extracellular signal in addition to an intracellular factor. (zhou2020hspa12bsecretedby pages 1-2)

### 3) Primary functions and pathway-level mechanisms (evidence-led)

A compact evidence table is provided first for readability, then narrative synthesis follows.

| Functional role / process | Mechanistic pathway | Experimental system / model | Key quantitative results | Main citation IDs |
|---|---|---|---|---|
| Endothelial angiogenesis after myocardial infarction | HSPA12B is a YAP/TEAD4 target and coactivator; hypoxia induces HSPA12B nuclear translocation, HSPA12B-YAP interaction, YAP stabilization, and angiogenic gene induction (e.g., Ang1, VEGF, VEGFR2, CTGF, MFAP5) | HUVEC hypoxia assays; endothelial-specific Hspa12b knockout and MI mouse model | Ad-HSPA12B increased HUVEC proliferation by 24.6% (EdU) and 15.2% (MTT), migration by 36.7%; YAP inhibition reduced Ang1 and VEGF mRNA by 56.7% and 51.3%; endothelial Hspa12b loss decreased post-MI CD31+ vessel area by 54.4%; MI increased cytosolic/nuclear HSPA12B by 112.7% | (fan2020endothelialcellhspa12b pages 1-2, fan2020endothelialcellhspa12b pages 2-4, fan2020endothelialcellhspa12b pages 6-8) |
| Cardiac functional preservation after MI | Same HSPA12B-YAP axis linked to preserved angiogenesis and ventricular performance | Endothelial-specific Hspa12b-/- and endothelial Yap-/- mice after MI | eHspa12b-/- MI hearts: EF 36.7% ± 2.36 vs 46.6% ± 5.67 in WT; FS 17.1% ± 1.20 vs 22.7% ± 3.40. eYap-/- MI hearts: EF 38.0% ± 4.26 vs 46.0% ± 4.41 in WT; FS 17.9% ± 2.27 vs 22.3% ± 2.42 | (fan2020endothelialcellhspa12b pages 8-11, fan2020endothelialcellhspa12b media e4c95a7b) |
| Sepsis-induced cardiomyopathy protection | HSPA12B upregulates miR-126, suppressing endothelial adhesion molecules ICAM-1 and VCAM-1, reducing inflammatory cell infiltration | CLP polymicrobial sepsis in endothelial HSPA12B-deficient mice; HUVEC LPS assays; exosome transfer experiments | HSPA12B-/- mice reached 50% mortality at 40 h vs 56 h in WT and 100% mortality by 60 h vs 100 h in WT; septic HSPA12B-/- hearts had EF 20.5% and FS 22.8%; VCAM-1 and ICAM-1 were 173% and 191% higher vs WT septic; serum TNFα and IL-6 were 243% and 223% higher vs WT septic | (zhang2020endothelialhspa12bexerts pages 1-2, zhang2020endothelialhspa12bexerts pages 4-6, zhang2020endothelialhspa12bexerts pages 3-4) |
| Exosomal miR-126 rescue in sepsis | Reduced HSPA12B lowers circulating exosomal miR-126; exosomal miR-126 delivery reverses adhesion-molecule upregulation and cardiac dysfunction | CLP sepsis mice; BMSC-derived miR-126-loaded exosomes; endothelial recipient-cell assays | WT septic exosomes increased VCAM-1 by 87.2% and ICAM-1 by 157.3% vs WT sham; HSPA12B-/- septic exosomes induced an additional 75.1% and 78.9% increase vs WT septic exosomes; miR-126 exosome delivery raised serum miR-126 by 178%, increased EF by 47.8% and FS by 61.2% | (zhang2020endothelialhspa12bexerts pages 13-15, zhang2020endothelialhspa12bexerts pages 12-13) |
| Anti-inflammatory control during sepsis | HSPA12B restrains NF-κB activation and leukocyte recruitment in myocardium | CLP sepsis in endothelial HSPA12B-deficient mice | Myocardial NF-κB binding activity increased 36.8% in WT septic and 82.3% in HSPA12B-/- septic mice vs sham; neutrophil accumulation was ~72-88% higher and macrophage accumulation 57.9% higher in HSPA12B-/- septic mice vs WT septic | (zhang2020endothelialhspa12bexerts pages 4-6, zhang2020endothelialhspa12bexerts pages 6-12) |
| Endothelial exosomal HSPA12B immunomodulates macrophages after sepsis | Endothelial exosomal HSPA12B is taken up by macrophages, increases IL-10, decreases TNF-α/IL-1β, and suppresses NF-κB activation/nuclear translocation | Endothelial cell-derived exosomes; LPS-stimulated macrophages; CLP sepsis model | Directional effects reported: higher mortality, worse cardiac dysfunction, and more myocardial/splenic macrophage infiltration in HSPA12B-deficient septic mice; exosomal HSPA12B shifted macrophages toward anti-inflammatory cytokine output | (tu2020novelroleof pages 1-2) |
| Post-MI macrophage reprogramming by endothelial HSPA12B (newer evidence) | Endothelial-secreted exosomal HSPA12B drives pro-regenerative macrophage phenotype by promoting TLR4 and MyD88 degradation after uptake | Endothelial-specific Hspa12b knockout mice post-MI; endothelial conditioned medium/exosomes; RAW264.7 and BMDMs | eHspa12b-/- mice had significantly worsened cardiac function and increased infiltrating CCR2+ monocytes at day 3 post-MI; ECCM from HSPA12B-overexpressing endothelial cells reduced iNOS and increased Arg-1 in macrophages; exosomes from Ad-HSPA12B endothelial cells contained higher HSPA12B | (wang2025endothelialhspa12bregulates pages 1-2, wang2025endothelialhspa12bregulates pages 5-7) |
| Tumor microenvironment immune modulation | Tumor endothelial-secreted HSPA12B is taken up by macrophages partly via OLR1 and activates PI3K/Akt/mTOR to promote M2 polarization | HNSC bulk and single-cell datasets; tumor-associated endothelial cells; RAW264.7 macrophages | Single-cell dataset included >2000 tumor cells, 1440 fibroblasts, 260 endothelial cells, and 98 macrophages; exogenous HSPA12B increased CD163/CD206 in a dose-dependent manner, while OLR1 knockdown or LY294002 attenuated uptake/signaling and M2-marker induction | (zhou2020hspa12bsecretedby pages 1-2) |
| Functional recovery after ischemic stroke | HSPA12B promotes peri-infarct angiogenesis and neurogenesis through an eNOS-dependent mechanism, with associated TGF-β1 increase | HSPA12B transgenic mice subjected to 60 min MCAO; pharmacologic eNOS inhibition with L-NAME | HSPA12B Tg mice showed significantly higher 28-day survival, improved neurological function within 21 days, enhanced angiogenesis at day 28 and neurogenesis at day 7; L-NAME abolished the protective effect | (zhao2018hspa12bpromotesfunctional pages 1-2) |


*Table: This table summarizes evidence-backed functional roles, mechanisms, model systems, and quantitative findings for human HSPA12B across cardiovascular, inflammatory, and tumor-related contexts. It highlights where the strongest mechanistic support exists for functional annotation.*

#### 3.1 Cardiovascular repair: angiogenesis after myocardial infarction (MI)
**Core concept:** endothelial HSPA12B promotes post-ischemic angiogenesis and improves cardiac function.

**Mechanism (Hippo/YAP transcriptional axis):** In endothelial cells, hypoxia induces HSPA12B nuclear translocation and **physical interaction with YAP and TEAD4**. The gene **HSPA12B is reported to be a transcriptional target of YAP/TEAD4**, and HSPA12B also functions as a **coactivator** at YAP/TEAD4-driven promoters (e.g., CTGF). HSPA12B additionally stabilizes YAP (e.g., protection from proteasomal degradation), supporting nuclear YAP signaling. (fan2020endothelialcellhspa12b pages 1-2, fan2020endothelialcellhspa12b pages 6-8)

**Functional cellular outputs:** Overexpressing HSPA12B in HUVECs under hypoxia increases proliferation (EdU +24.6%; MTT +15.2%), migration (+36.7%), and tube formation, while YAP inhibition blunts HSPA12B-driven angiogenic gene expression (Ang1 and VEGF mRNA reduced by 56.7% and 51.3%). (fan2020endothelialcellhspa12b pages 2-4)

**In vivo outcomes (quantitative):** Endothelial-specific Hspa12b loss worsens post-MI function (EF 36.7% ± 2.36 vs 46.6% ± 5.67 in WT; FS 17.1% ± 1.20 vs 22.7% ± 3.40) and reduces angiogenesis (CD31 staining decreased; vessel area quantified in the source figure set). (fan2020endothelialcellhspa12b pages 8-11, fan2020endothelialcellhspa12b media e4c95a7b)

#### 3.2 Sepsis cardiomyopathy: endothelial barrier/inflammation control via miR-126 and NF-κB
**Core concept:** endothelial HSPA12B protects against polymicrobial sepsis-induced cardiac dysfunction by restraining endothelial activation and immune cell infiltration.

**Mechanism A (miR-126 → adhesion molecules):** In a CLP model, HSPA12B deficiency is associated with lower **exosomal miR-126**, an endothelial miRNA that suppresses adhesion molecules, and with increased myocardial **VCAM-1/ICAM-1** expression, promoting leukocyte infiltration. Exosomal delivery of miR-126 rescues key phenotypes (adhesion molecules and cardiac function). (zhang2020endothelialhspa12bexerts pages 13-15, zhang2020endothelialhspa12bexerts pages 12-13)

**Mechanism B (NF-κB activity):** Myocardial NF-κB binding activity rises markedly in sepsis and is higher with HSPA12B deficiency (82.3% increase vs sham in HSPA12B−/− vs 36.8% in WT septic mice). Serum TNFα and IL-6 were 243% and 223% higher in HSPA12B−/− septic mice than WT septic, consistent with amplified systemic inflammation. (zhang2020endothelialhspa12bexerts pages 4-6, zhang2020endothelialhspa12bexerts pages 6-12)

**Quantitative outcomes:** In one report, WT mice had 50% mortality at 56 h and 100% mortality by 100 h, whereas HSPA12B−/− mice had 50% mortality at 40 h and 100% mortality by 60 h (P<0.01). (zhang2020endothelialhspa12bexerts pages 3-4)

#### 3.3 Endothelial–macrophage crosstalk via exosomal HSPA12B
In a polymicrobial sepsis context, endothelial-derived exosomes containing HSPA12B are described as being **taken up by macrophages**, resulting in **increased IL-10** and **decreased TNF-α/IL-1β** production in LPS-stimulated macrophages, with **suppressed NF-κB activation/nuclear translocation**. This positions HSPA12B as an endothelial anti-inflammatory “message” delivered to innate immune cells. (tu2020novelroleof pages 1-2)

A newer MI-focused mechanistic extension reports that uptake of HSPA12B-containing endothelial exosomes promotes degradation of **TLR4 and MyD88** in macrophages, linking HSPA12B to reduced innate immune receptor signaling and pro-regenerative macrophage polarization after MI. (wang2025endothelialhspa12bregulates pages 1-2)

#### 3.4 Tumor microenvironment immunomodulation: secreted HSPA12B → macrophage M2 polarization
In head and neck squamous cell carcinoma analyses, tumor-associated endothelial cells are reported to express and secrete higher HSPA12B than normal endothelial cells, and exogenous HSPA12B drives macrophage M2 marker expression (CD163/CD206) dose-dependently. Uptake is partly mediated by **OLR1** (described as an HSP70 receptor), and downstream signaling involves dose-dependent increases in **p-PI3K/p-Akt/p-mTOR**, supporting a PI3K/Akt/mTOR-dependent polarization mechanism. (zhou2020hspa12bsecretedby pages 1-2)

#### 3.5 Neurovascular repair: ischemic stroke recovery via eNOS
In a mouse stroke model, HSPA12B overexpression improves survival and neurologic recovery and augments peri-infarct angiogenesis, with protective effects diminished by eNOS inhibition (L-NAME), supporting an **eNOS-dependent** mechanism. In brain tissue, HSPA12B expression increased 5.7-fold at 24 h post-stroke vs sham (P<0.01). (zhao2018hspa12bpromotesfunctional pages 1-2, zhao2018hspa12bpromotesfunctional pages 3-3)

### 4) Recent developments (prioritizing 2023–2024)
Mechanism-discovery primary literature directly focused on HSPA12B remains relatively concentrated in 2018–2020 (with additional 2025 mechanistic work retrieved), but **2023–2024 sources** provide updated **translational framing** around **extracellular vesicles/exosome-based interventions**:

- A 2024 review on engineered exosomes for septic cardiomyopathy highlights **endothelial HSPA12B** as a **protective HSP70-family factor** and notes preclinical findings that exosomes enriched in endothelial HSPA12B can inhibit NF-κB activation in LPS-stimulated macrophages—positioning HSPA12B as a candidate **therapeutic exosome cargo**. (Mao et al., 2024-06; https://doi.org/10.3389/fcvm.2024.1399738) (mao2024engineeredexosomesa pages 6-8)

- A 2023 review on EV therapeutics in cardiovascular disease cites prior work describing HSPA12B as endothelial-specific and protective in sepsis cardiomyopathy via suppression of adhesion molecules by miR-126, supporting the concept that **vascular protective effects can be mediated by EV-associated signals** (though not adding new quantitative results itself). (Francés et al., 2023-07; https://doi.org/10.3390/biomedicines11071907) (frances2023therapeuticpotentialof pages 28-30)

### 5) Current applications and real-world implementations

#### 5.1 Biomarker development: sepsis/severe sepsis
A completed prospective observational case-control study registered on ClinicalTrials.gov evaluated **plasma HSPA12B as a potential biomarker** for sepsis and severe sepsis (NCT01847248; Changhai Hospital). The registry states the hypothesis that endothelial injury markers may stratify severe sepsis and that HSPA12B is detectable during sepsis, with **28-day mortality** as the primary outcome and **118 enrolled participants** across sepsis, severe sepsis, SIRS (post-orthopedic surgery), and healthy controls; study dates 2011–2013. (https://clinicaltrials.gov/study/NCT01847248) (NCT01847248 chunk 1)

#### 5.2 Therapeutic concepts: engineered exosomes and endothelial protective cargo
Recent reviews place HSPA12B in a **candidate therapeutic payload** category for engineered exosome strategies aimed at modulating macrophage activation and septic cardiomyopathy pathobiology, but these remain **preclinical** in evidence base as summarized in the review excerpt. (mao2024engineeredexosomesa pages 6-8)

#### 5.3 Genetic association signals (human cohort)
A pilot genetic association study (International Journal of Molecular Sciences, 2025-09; https://doi.org/10.3390/ijms26188967) genotyped 1228 subjects and reported that **HSPA12B SNP rs910652 (effect allele C)** was associated with **decreased risk of severe COVID-19** (p=0.01 overall; p=0.04 in females). While not a direct functional annotation, this provides real-world human evidence that regulatory variation at the HSPA12B locus may modulate inflammatory disease severity. (karpenko2025genesencodingheat pages 1-2)

### 6) Expert synthesis / analysis (what is most likely the “primary function”)

**Most strongly supported functional role (by mechanistic and phenotype evidence):** HSPA12B functions as an **endothelial stress-response effector** that (i) enables **adaptive vascular remodeling/angiogenesis** in ischemic injury and (ii) constrains **endothelial-driven inflammation** through regulation of adhesion molecules and exosome-mediated immune modulation. These roles are repeatedly supported by targeted gain/loss experiments and physiologic endpoints (cardiac function, mortality, angiogenesis measures). (fan2020endothelialcellhspa12b pages 1-2, fan2020endothelialcellhspa12b pages 6-8, zhang2020endothelialhspa12bexerts pages 4-6, zhang2020endothelialhspa12bexerts pages 3-4)

**How this fits with “HSP70-family” membership:** while HSPA12B is classified within HSP70 family, a key caveat is that its **divergent NBD** suggests its **biochemical mechanism may differ from canonical ATPase-driven chaperoning**, and many demonstrated effects are mediated through **signaling/transcriptional programs** (YAP/TEAD4; NF-κB; PI3K/Akt/mTOR; eNOS; TLR4/MyD88) and intercellular communication (exosomes). (madsen2019hspa12atargetsthe pages 1-2, fan2020endothelialcellhspa12b pages 6-8, zhou2020hspa12bsecretedby pages 1-2, tu2020novelroleof pages 1-2)

### 7) Data highlights (statistics from recent/primary studies)
Key quantitative findings from primary studies include:
- **Post-MI cardiac function:** EF and FS reductions in endothelial Hspa12b-/- vs WT (EF 36.7% ± 2.36 vs 46.6% ± 5.67; FS 17.1% ± 1.20 vs 22.7% ± 3.40). (fan2020endothelialcellhspa12b pages 8-11, fan2020endothelialcellhspa12b media e4c95a7b)
- **Hypoxia HUVEC functional effects of HSPA12B:** proliferation (+24.6% EdU), migration (+36.7%); and dependence on YAP activity (e.g., Ang1/VEGF mRNA reductions with YAP inhibition). (fan2020endothelialcellhspa12b pages 2-4)
- **Sepsis survival:** 50% mortality at 40 h in HSPA12B−/− vs 56 h in WT; 100% mortality by 60 h vs 100 h (P<0.01). (zhang2020endothelialhspa12bexerts pages 3-4)
- **Sepsis inflammation:** serum TNFα and IL-6 243% and 223% higher in HSPA12B−/− septic mice vs WT septic; myocardial NF-κB binding activity 82.3% vs 36.8% increases (vs sham). (zhang2020endothelialhspa12bexerts pages 4-6, zhang2020endothelialhspa12bexerts pages 6-12)

### 8) Disease associations (database-level evidence)
OpenTargets lists disease–target associations for **HSPA12B** including **myocardial infarction** and **sepsis**, consistent with the mechanistic cardiovascular and inflammatory literature above (and additional associations such as neurodegenerative disease and cancers). (OpenTargets Search: -HSPA12B)

### 9) Limitations and evidence gaps
- **Direct biochemical function remains unclear:** the atypical/divergent NBD is described, but definitive evidence for HSPA12B’s ATPase kinetics, nucleotide specificity, and classical client-protein repertoire is not established in the retrieved mechanistic excerpts. (madsen2019hspa12atargetsthe pages 1-2)
- **Human evidence is limited but emerging:** the ClinicalTrials.gov biomarker study provides real-world intent and cohort structure, but the registry excerpt does not provide diagnostic performance statistics (AUC/sensitivity/specificity) or measured concentration distributions. (NCT01847248 chunk 1)
- **2023–2024 primary mechanistic papers on HSPA12B itself were limited in this retrieval:** recent years mainly contribute review-level synthesis and translational framing, while many mechanistic experiments are from 2018–2020 (with a 2025 mechanistic extension retrieved). (mao2024engineeredexosomesa pages 6-8, wang2025endothelialhspa12bregulates pages 1-2)

### Evidence-bearing figures (visual)
Quantified post-MI cardiac function and angiogenesis data (EF/FS, CD31 vessel area) are shown in the retrieved figure crops from Fan et al. 2020. (fan2020endothelialcellhspa12b media e4c95a7b, fan2020endothelialcellhspa12b media c7b04766, fan2020endothelialcellhspa12b media 0425e8c2, fan2020endothelialcellhspa12b media 92ef776f)


References

1. (fan2020endothelialcellhspa12b pages 1-2): Min Fan, Kun Yang, Xiaohui Wang, Yana Wang, Fei Tu, Tuanzhu Ha, Li Liu, David L. Williams, and Chuanfu Li. Endothelial cell hspa12b and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction. JCI Insight, Sep 2020. URL: https://doi.org/10.1172/jci.insight.139640, doi:10.1172/jci.insight.139640. This article has 39 citations and is from a domain leading peer-reviewed journal.

2. (zhang2020endothelialhspa12bexerts pages 1-2): Xia Zhang, Xiaohui Wang, Min Fan, Fei Tu, Kun Yang, Tuanzhu Ha, Li Liu, John Kalbfleisch, David Williams, and Chuanfu Li. Endothelial hspa12b exerts protection against sepsis-induced severe cardiomyopathy via suppression of adhesion molecule expression by mir-126. Frontiers in Immunology, Apr 2020. URL: https://doi.org/10.3389/fimmu.2020.00566, doi:10.3389/fimmu.2020.00566. This article has 45 citations and is from a peer-reviewed journal.

3. (tu2020novelroleof pages 1-2): Fei Tu, Xiaohui Wang, Xia Zhang, Tuanzhu Ha, Yana Wang, Min Fan, Kun Yang, P. Spencer Gill, Tammy R. Ozment, Yuan Dai, Li Liu, David L. Williams, and Chuanfu Li. Novel role of endothelial derived exosomal hspa12b in regulating macrophage inflammatory responses in polymicrobial sepsis. Frontiers in Immunology, May 2020. URL: https://doi.org/10.3389/fimmu.2020.00825, doi:10.3389/fimmu.2020.00825. This article has 61 citations and is from a peer-reviewed journal.

4. (madsen2019hspa12atargetsthe pages 1-2): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

5. (zhang2020endothelialhspa12bexerts pages 13-15): Xia Zhang, Xiaohui Wang, Min Fan, Fei Tu, Kun Yang, Tuanzhu Ha, Li Liu, John Kalbfleisch, David Williams, and Chuanfu Li. Endothelial hspa12b exerts protection against sepsis-induced severe cardiomyopathy via suppression of adhesion molecule expression by mir-126. Frontiers in Immunology, Apr 2020. URL: https://doi.org/10.3389/fimmu.2020.00566, doi:10.3389/fimmu.2020.00566. This article has 45 citations and is from a peer-reviewed journal.

6. (fan2020endothelialcellhspa12b pages 6-8): Min Fan, Kun Yang, Xiaohui Wang, Yana Wang, Fei Tu, Tuanzhu Ha, Li Liu, David L. Williams, and Chuanfu Li. Endothelial cell hspa12b and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction. JCI Insight, Sep 2020. URL: https://doi.org/10.1172/jci.insight.139640, doi:10.1172/jci.insight.139640. This article has 39 citations and is from a domain leading peer-reviewed journal.

7. (wang2025endothelialhspa12bregulates pages 1-2): Yana Wang, Min Fan, Linjian Chen, Patrick Spencer Gill, Xiaohui Wang, Tuanzhu Ha, David L. Williams, Chuanfu Li, and Kun Yang. Endothelial hspa12b regulates myocardial monocyte infiltration and inflammatory activity after myocardial infarction. Frontiers in Immunology, May 2025. URL: https://doi.org/10.3389/fimmu.2025.1587898, doi:10.3389/fimmu.2025.1587898. This article has 3 citations and is from a peer-reviewed journal.

8. (zhou2020hspa12bsecretedby pages 1-2): Jingjie Zhou, Aiping Zhang, and Liang Fan. Hspa12b secreted by tumor-associated endothelial cells might induce m2 polarization of macrophages via activating pi3k/akt/mtor signaling. OncoTargets and therapy, 13:9103-9111, Sep 2020. URL: https://doi.org/10.2147/ott.s254985, doi:10.2147/ott.s254985. This article has 29 citations.

9. (fan2020endothelialcellhspa12b pages 2-4): Min Fan, Kun Yang, Xiaohui Wang, Yana Wang, Fei Tu, Tuanzhu Ha, Li Liu, David L. Williams, and Chuanfu Li. Endothelial cell hspa12b and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction. JCI Insight, Sep 2020. URL: https://doi.org/10.1172/jci.insight.139640, doi:10.1172/jci.insight.139640. This article has 39 citations and is from a domain leading peer-reviewed journal.

10. (fan2020endothelialcellhspa12b pages 8-11): Min Fan, Kun Yang, Xiaohui Wang, Yana Wang, Fei Tu, Tuanzhu Ha, Li Liu, David L. Williams, and Chuanfu Li. Endothelial cell hspa12b and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction. JCI Insight, Sep 2020. URL: https://doi.org/10.1172/jci.insight.139640, doi:10.1172/jci.insight.139640. This article has 39 citations and is from a domain leading peer-reviewed journal.

11. (fan2020endothelialcellhspa12b media e4c95a7b): Min Fan, Kun Yang, Xiaohui Wang, Yana Wang, Fei Tu, Tuanzhu Ha, Li Liu, David L. Williams, and Chuanfu Li. Endothelial cell hspa12b and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction. JCI Insight, Sep 2020. URL: https://doi.org/10.1172/jci.insight.139640, doi:10.1172/jci.insight.139640. This article has 39 citations and is from a domain leading peer-reviewed journal.

12. (zhang2020endothelialhspa12bexerts pages 4-6): Xia Zhang, Xiaohui Wang, Min Fan, Fei Tu, Kun Yang, Tuanzhu Ha, Li Liu, John Kalbfleisch, David Williams, and Chuanfu Li. Endothelial hspa12b exerts protection against sepsis-induced severe cardiomyopathy via suppression of adhesion molecule expression by mir-126. Frontiers in Immunology, Apr 2020. URL: https://doi.org/10.3389/fimmu.2020.00566, doi:10.3389/fimmu.2020.00566. This article has 45 citations and is from a peer-reviewed journal.

13. (zhang2020endothelialhspa12bexerts pages 3-4): Xia Zhang, Xiaohui Wang, Min Fan, Fei Tu, Kun Yang, Tuanzhu Ha, Li Liu, John Kalbfleisch, David Williams, and Chuanfu Li. Endothelial hspa12b exerts protection against sepsis-induced severe cardiomyopathy via suppression of adhesion molecule expression by mir-126. Frontiers in Immunology, Apr 2020. URL: https://doi.org/10.3389/fimmu.2020.00566, doi:10.3389/fimmu.2020.00566. This article has 45 citations and is from a peer-reviewed journal.

14. (zhang2020endothelialhspa12bexerts pages 12-13): Xia Zhang, Xiaohui Wang, Min Fan, Fei Tu, Kun Yang, Tuanzhu Ha, Li Liu, John Kalbfleisch, David Williams, and Chuanfu Li. Endothelial hspa12b exerts protection against sepsis-induced severe cardiomyopathy via suppression of adhesion molecule expression by mir-126. Frontiers in Immunology, Apr 2020. URL: https://doi.org/10.3389/fimmu.2020.00566, doi:10.3389/fimmu.2020.00566. This article has 45 citations and is from a peer-reviewed journal.

15. (zhang2020endothelialhspa12bexerts pages 6-12): Xia Zhang, Xiaohui Wang, Min Fan, Fei Tu, Kun Yang, Tuanzhu Ha, Li Liu, John Kalbfleisch, David Williams, and Chuanfu Li. Endothelial hspa12b exerts protection against sepsis-induced severe cardiomyopathy via suppression of adhesion molecule expression by mir-126. Frontiers in Immunology, Apr 2020. URL: https://doi.org/10.3389/fimmu.2020.00566, doi:10.3389/fimmu.2020.00566. This article has 45 citations and is from a peer-reviewed journal.

16. (wang2025endothelialhspa12bregulates pages 5-7): Yana Wang, Min Fan, Linjian Chen, Patrick Spencer Gill, Xiaohui Wang, Tuanzhu Ha, David L. Williams, Chuanfu Li, and Kun Yang. Endothelial hspa12b regulates myocardial monocyte infiltration and inflammatory activity after myocardial infarction. Frontiers in Immunology, May 2025. URL: https://doi.org/10.3389/fimmu.2025.1587898, doi:10.3389/fimmu.2025.1587898. This article has 3 citations and is from a peer-reviewed journal.

17. (zhao2018hspa12bpromotesfunctional pages 1-2): Yanlin Zhao, Chang Liu, Jiali Liu, Qiuyue Kong, Yu Mao, Hao Cheng, Nan-yi Li, Xioajin Zhang, Chuanful Li, Yuehua Li, Li Liu, and Zhengnian Ding. Hspa12b promotes functional recovery after ischaemic stroke through an enos‐dependent mechanism. Journal of Cellular and Molecular Medicine, 22:2252-2262, Feb 2018. URL: https://doi.org/10.1111/jcmm.13507, doi:10.1111/jcmm.13507. This article has 15 citations and is from a peer-reviewed journal.

18. (zhao2018hspa12bpromotesfunctional pages 3-3): Yanlin Zhao, Chang Liu, Jiali Liu, Qiuyue Kong, Yu Mao, Hao Cheng, Nan-yi Li, Xioajin Zhang, Chuanful Li, Yuehua Li, Li Liu, and Zhengnian Ding. Hspa12b promotes functional recovery after ischaemic stroke through an enos‐dependent mechanism. Journal of Cellular and Molecular Medicine, 22:2252-2262, Feb 2018. URL: https://doi.org/10.1111/jcmm.13507, doi:10.1111/jcmm.13507. This article has 15 citations and is from a peer-reviewed journal.

19. (mao2024engineeredexosomesa pages 6-8): Lixia Mao, Songtao Liu, Yongxia Chen, Huiyi Huang, Fenghua Ding, and Liehua Deng. Engineered exosomes: a potential therapeutic strategy for septic cardiomyopathy. Frontiers in Cardiovascular Medicine, Jun 2024. URL: https://doi.org/10.3389/fcvm.2024.1399738, doi:10.3389/fcvm.2024.1399738. This article has 9 citations and is from a peer-reviewed journal.

20. (frances2023therapeuticpotentialof pages 28-30): Javier Laura Francés, Christina Pagiatakis, Vittoria Di Mauro, and Montserrat Climent. Therapeutic potential of evs: targeting cardiovascular diseases. Biomedicines, 11:1907, Jul 2023. URL: https://doi.org/10.3390/biomedicines11071907, doi:10.3390/biomedicines11071907. This article has 33 citations.

21. (NCT01847248 chunk 1): Jia-feng Wang. HSPA12B as a Potential Biomarker for Sepsis and Severe Sepsis. Changhai Hospital. 2011. ClinicalTrials.gov Identifier: NCT01847248

22. (karpenko2025genesencodingheat pages 1-2): Andrey R. Karpenko, Ksenia A. Kobzeva, Yuriy L. Orlov, and Olga Yu. Bushueva. Genes encoding heat shock proteins are associated with risk and clinical course of severe covid-19: a pilot study. International Journal of Molecular Sciences, 26:8967, Sep 2025. URL: https://doi.org/10.3390/ijms26188967, doi:10.3390/ijms26188967. This article has 0 citations.

23. (OpenTargets Search: -HSPA12B): Open Targets Query (-HSPA12B, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

24. (fan2020endothelialcellhspa12b media c7b04766): Min Fan, Kun Yang, Xiaohui Wang, Yana Wang, Fei Tu, Tuanzhu Ha, Li Liu, David L. Williams, and Chuanfu Li. Endothelial cell hspa12b and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction. JCI Insight, Sep 2020. URL: https://doi.org/10.1172/jci.insight.139640, doi:10.1172/jci.insight.139640. This article has 39 citations and is from a domain leading peer-reviewed journal.

25. (fan2020endothelialcellhspa12b media 0425e8c2): Min Fan, Kun Yang, Xiaohui Wang, Yana Wang, Fei Tu, Tuanzhu Ha, Li Liu, David L. Williams, and Chuanfu Li. Endothelial cell hspa12b and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction. JCI Insight, Sep 2020. URL: https://doi.org/10.1172/jci.insight.139640, doi:10.1172/jci.insight.139640. This article has 39 citations and is from a domain leading peer-reviewed journal.

26. (fan2020endothelialcellhspa12b media 92ef776f): Min Fan, Kun Yang, Xiaohui Wang, Yana Wang, Fei Tu, Tuanzhu Ha, Li Liu, David L. Williams, and Chuanfu Li. Endothelial cell hspa12b and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction. JCI Insight, Sep 2020. URL: https://doi.org/10.1172/jci.insight.139640, doi:10.1172/jci.insight.139640. This article has 39 citations and is from a domain leading peer-reviewed journal.

## Citations

1. tu2020novelroleof pages 1-2
2. mao2024engineeredexosomesa pages 6-8
3. frances2023therapeuticpotentialof pages 28-30
4. karpenko2025genesencodingheat pages 1-2
5. https://doi.org/10.3389/fcvm.2024.1399738
6. https://doi.org/10.3390/biomedicines11071907
7. https://clinicaltrials.gov/study/NCT01847248
8. https://doi.org/10.3390/ijms26188967
9. https://doi.org/10.1172/jci.insight.139640,
10. https://doi.org/10.3389/fimmu.2020.00566,
11. https://doi.org/10.3389/fimmu.2020.00825,
12. https://doi.org/10.1038/s41598-018-37336-6,
13. https://doi.org/10.3389/fimmu.2025.1587898,
14. https://doi.org/10.2147/ott.s254985,
15. https://doi.org/10.1111/jcmm.13507,
16. https://doi.org/10.3389/fcvm.2024.1399738,
17. https://doi.org/10.3390/biomedicines11071907,
18. https://doi.org/10.3390/ijms26188967,